Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Compound for inhibiting binding between DX2 protein and P14/ARF protein, and pharmaceutical composition for treating or preventing cancer disease containing same as effective ingredient

US Patent 10072021 · Granted Sep 11, 2018

Assignee

Inventors

View full patent text on Google Patents →